Concanavalin a affinity chromatography for efficient baculovirus purification

Baculovirus has emerged as a novel gene delivery and vaccine vector, and the demand for purified baculovirus is rising due to the increasing in vivo applications. Since the baculoviral envelope protein gp64 is a glycoprotein, we aimed to develop a concanavalin A (Con A) chromatography process, which harnessed the possible affinity interaction between gp64 and Con A, for simple and effective baculovirus purification. Throughout the purification process the virus stability and recovery were assessed by quantifying the virus transducing titers [TT, defined as transducing units (TU) per milliliter] and viral particles (VP). We found that baculovirus stability was sensitive to buffer conditions and diafiltration with a tangential flow filtration system LabScale using 300 K membranes yielded recoveries of ≈75% in TT and 82% in VP. The diafiltered baculovirus strongly bound to the Con A column as evidenced by the low virus losses to the flow through and wash fractions. The wash steps eliminated >99% of protein impurities and elution with 0.6 M α‐D‐methylmannoside at room temperature led to the recoveries of ≈16% in VP and ≈15.3% in TU. The resultant VP/TU ratio was as low as 41.4, attesting the high quality of the purified virus. Further elution with 1 M α‐D‐methylmannoside recovered another 6% virus TU, yielding a cumulative recovery of ≈21.3% in TU. These data demonstrated for the first time that Con A chromatography is suitable for baculovirus purification, and may be used for the purification of other viruses with surface glycoproteins. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009

[1]  K. Airenne,et al.  Targeting and purification of metabolically biotinylated baculovirus. , 2008, Human gene therapy.

[2]  K. Airenne,et al.  Generation of lentivirus vectors using recombinant baculoviruses , 2008, Gene Therapy.

[3]  Li-Yu Sung,et al.  Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation , 2008, Gene Therapy.

[4]  Yu-Chen Hu Baculoviral vectors for gene delivery: a review. , 2008, Current gene therapy.

[5]  Y. Matsuura,et al.  Baculovirus vector for gene delivery and vaccine development , 2008 .

[6]  Y. Lai,et al.  Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. , 2007, Human gene therapy.

[7]  Y. Durocher,et al.  Production of lentiviral vectors by large‐scale transient transfection of suspension cultures and affinity chromatography purification , 2007, Biotechnology and bioengineering.

[8]  Li-Yu Sung,et al.  Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering , 2007, Gene Therapy.

[9]  Chunxiao Wu,et al.  Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. , 2007, Human gene therapy.

[10]  A. Kamen,et al.  High yield purification of functional baculovirus vectors by size exclusion chromatography. , 2007, Journal of virological methods.

[11]  Thomas A Kost,et al.  Implementation of BacMam virus gene delivery technology in a drug discovery setting. , 2007, Drug discovery today.

[12]  Y. Lai,et al.  Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  D. Schaffer,et al.  Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography. , 2007, Human gene therapy.

[14]  K. Airenne,et al.  SPECT/CT imaging of baculovirus biodistribution in rat , 2007, Gene Therapy.

[15]  Yu-Chen Hu,et al.  Factors influencing the production and storage of baculovirus for gene delivery: An alternative perspective from the transducing titer assay , 2007 .

[16]  P. Cruz,et al.  Scaleable purification process for gene therapy retroviral vectors , 2007, The journal of gene medicine.

[17]  N. Palanisamy,et al.  Baculoviral Vector‐Mediated Transient and Stable Transgene Expression in Human Embryonic Stem Cells , 2007, Stem cells.

[18]  U. Reichl,et al.  Purification of cell culture‐derived human influenza A virus by size‐exclusion and anion‐exchange chromatography , 2006, Biotechnology and bioengineering.

[19]  A. Kamen,et al.  Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. , 2007, Journal of virological methods.

[20]  S. Tuve,et al.  Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  P. Czermak,et al.  Purification of Densonucleosis Virus by Tangential Flow Ultrafiltration , 2008, Biotechnology progress (Print).

[22]  M. V. van Oers Vaccines for Viral and Parasitic Diseases Produced with Baculovirus Vectors , 2006, Advances in Virus Research.

[23]  C. Oker-Blom,et al.  Baculovirus Display: A Multifunctional Technology for Gene Delivery and Eukaryotic Library Development , 2006, Advances in Virus Research.

[24]  J. Bartlett,et al.  Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Yi-Chen Ho,et al.  Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states , 2006, Gene Therapy.

[26]  P. Alves,et al.  Effect of osmotic pressure on the production of retroviral vectors: Enhancement in vector stability , 2006, Biotechnology and bioengineering.

[27]  A. Kamen,et al.  Analysis of baculovirus aggregates using flow cytometry. , 2006, Journal of virological methods.

[28]  Shu Wang,et al.  Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. , 2006, Cancer research.

[29]  Yu-Chen Hu,et al.  Determination of the baculovirus transducing titer in mammalian cells , 2006, Biotechnology and bioengineering.

[30]  Arvind H. Patel,et al.  Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. , 2006, Biochemical and biophysical research communications.

[31]  K. Airenne,et al.  Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo , 2006, Gene Therapy.

[32]  M. M. Oers,et al.  Vaccines for viral and parasitic diseases produced with baculovirus vectors. , 2006 .

[33]  R. Ames,et al.  Baculoviruses and mammalian cell-based assays for drug screening. , 2006, Advances in virus research.

[34]  U. Reichl,et al.  Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. , 2005, Biotechnology and bioengineering.

[35]  V. Baekelandt,et al.  Upscaling of lentiviral vector production by tangential flow filtration , 2005, The journal of gene medicine.

[36]  A. Kamen,et al.  A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. , 2005, Biotechnology and bioengineering.

[37]  Thomas A Kost,et al.  Baculovirus as versatile vectors for protein expression in insect and mammalian cells , 2005, Nature Biotechnology.

[38]  J. Carlsson,et al.  Preparation of high-density Concanavalin A adsorbent and its use for rapid, high-yield purification of peroxidase from horseradish roots. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[39]  G. Nemerow,et al.  Membrane Cofactor Protein Is a Receptor for Adenoviruses Associated with Epidemic Keratoconjunctivitis , 2004, Journal of Virology.

[40]  Masayoshi Onishi,et al.  In Vitro and In Vivo Gene Delivery by Recombinant Baculoviruses , 2003, Journal of Virology.

[41]  J. Hsu,et al.  Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography , 2003 .

[42]  A. Cámara-Artigas,et al.  Purification of angiotensin I converting enzyme from pig lung using concanavalin-A sepharose chromatography. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[43]  Marcel Kuiper,et al.  Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography , 2002, Biotechnology and bioengineering.

[44]  M. O. Scott,et al.  A new scalable method for the purification of recombinant adenovirus vectors. , 2002, Human gene therapy.

[45]  A. Kamen,et al.  Quantitation of baculovirus particles by flow cytometry. , 2002, Journal of virological methods.

[46]  M. Ataai,et al.  Evaluation of Infection Parameters in the Production of Replication‐Defective HSV‐1 Viral Vectors , 2002, Biotechnology progress.

[47]  L. Volkman,et al.  Filamentous actin is required for lepidopteran nucleopolyhedrovirus progeny production. , 2000, Journal of General Virology.

[48]  J. Barsoum Concentration of recombinant baculovirus by cation-exchange chromatography. , 1999, BioTechniques.

[49]  D. O'reilly,et al.  Baculovirus expression vectors: a laboratory manual. , 1992 .

[50]  P. Ray,et al.  Differential binding affinity of immobilized Concanavalin A-Sepharose 4B for normal and myelomatous immunoglobulins. , 1982, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.